identifier	patientIdentifier	gene	rnaExpression	imputedGeneExpression	dnaVariantAlleleFrequency	rnaVariantAlleleFrequency	mutation.position	mutation.wildTypeXmer	mutation.mutatedXmer
1Zt9WWtj19BL03yx5QO/hQ==	34735899-1cd0-438f-b017-10ccd2f4367a	BRCA2	62.46	0.0	0.119	0.746	14	HLIQCIMDSQNKGKTSECSQVSPNYSR	HLIQCIMDSQNKGTTSECSQVSPNYSR
zNWEVdwZfChaHzm6dOtf2w==	34735899-1cd0-438f-b017-10ccd2f4367a	BRCA2	79.23	0.0	0.733	0.678	14	VKTLQVQAAQFAKQTGQWIGMVENFNQ	VKTLQVQAAQFAKDTGQWIGMVENFNQ
ASJTsX9BTP3FHSY/pm2aew==	34735899-1cd0-438f-b017-10ccd2f4367a	BRCA2	49.11	0.0	0.826	0.295	14	KTEGSVCLFKQAPSDPVSVLNWLLSDL	KTEGSVCLFKQAPLDPVSVLNWLLSDL
NpAzdEyboA3fg1gSrDwRJA==	34735899-1cd0-438f-b017-10ccd2f4367a	BRCA2	52.23	0.0	0.402	0.26	14	LSFPFSIIFSTVLYCGEVAFGLYMFEI	LSFPFSIIFSTVLLCGEVAFGLYMFEI
aguwIJ0BQdwDSJcQXH5NfA==	34735899-1cd0-438f-b017-10ccd2f4367a	BRCA2	49.57	0.0	0.675	0.387	14	PNEKMKQVLKKTIEEAKAIISKKQVEA	PNEKMKQVLKKTIIEAKAIISKKQVEA
LYsKhbiHbCOWt2Go+Bh/lg==	34735899-1cd0-438f-b017-10ccd2f4367a	BRCA2	26.15	0.0	0.539	0.507	14	TKAINGKYHRFLGRHFPRFYVLYTIFM	TKAINGKYHRFLGDHFPRFYVLYTIFM
pUhcagqxa8ANDpJA2WWjTg==	34735899-1cd0-438f-b017-10ccd2f4367a	BRCA2	17.83	0.0	0.733	0.11	14	LAGSDHSASLTDAGEVYVWGSNKHGQL	LAGSDHSASLTDAKEVYVWGSNKHGQL
7Bn6w5hPNqlXMhBnS2Gk0w==	34735899-1cd0-438f-b017-10ccd2f4367a	BRCA2	15.02	0.0	0.996	0.107	14	DGESLDEQPSSSSSKRSLLSRKFRGSK	DGESLDEQPSSSSWKRSLLSRKFRGSK
4xvrxmmNJMn9+J+QlZEGrQ==	34735899-1cd0-438f-b017-10ccd2f4367a	BRCA2	63.0	0.0	0.492	0.493	14	ITVHLLYGCPSLLHGPTLAGTVLGAAG	ITVHLLYGCPSLLRGPTLAGTVLGAAG
456j9bkVdDbdi7nBHBhRwA==	34735899-1cd0-438f-b017-10ccd2f4367a	BRCA2	50.33	0.0	0.589	0.337	14	ALVTLQRSPTPSAASSSASNSELEAGS	ALVTLQRSPTPSAQSSSASNSELEAGS
JCd0by/DzIbBnosWysOfLA==	c9bc1f95-2d8a-4e42-abca-ca1d16e19e37	BRCA2	63.45	0.0	0.908	0.785	14	FDLTPAKVLDASGHHETLIGEEQRPVF	FDLTPAKVLDASGCHETLIGEEQRPVF
+9Y20p6UFEF1xxw/cp8r0A==	c9bc1f95-2d8a-4e42-abca-ca1d16e19e37	BRCA2	76.31	0.0	0.253	0.586	14	PASQEPSPAASAEADGKLIQDSRRETK	PASQEPSPAASAESDGKLIQDSRRETK
p4rp5ROlmrCR1SxKRr/GWA==	c9bc1f95-2d8a-4e42-abca-ca1d16e19e37	BRCA2	56.45	0.0	0.196	0.814	14	IISTSSRSVMLHYRSDLLQMLDTLVFS	IISTSSRSVMLHYCSDLLQMLDTLVFS
D08QAKwavDr5FWm+kjuKlg==	c9bc1f95-2d8a-4e42-abca-ca1d16e19e37	BRCA2	24.34	0.0	0.752	0.211	14	RKRNNISILKEDPFLFCREIENGNSFD	RKRNNISILKEDPALFCREIENGNSFD
ENOmHBMETBzPW3TxIjMqVA==	c9bc1f95-2d8a-4e42-abca-ca1d16e19e37	BRCA2	13.53	0.0	0.88	0.771	14	DWPELQDDIPSILAQAQRILFVVDGLD	DWPELQDDIPSILKQAQRILFVVDGLD
EOk7sgflJI3FT+hDsTb2gg==	c9bc1f95-2d8a-4e42-abca-ca1d16e19e37	BRCA2	43.43	0.0	0.915	0.169	14	VMFMATTKYRQGSIDCTLTFSHPTWYW	VMFMATTKYRQGSFDCTLTFSHPTWYW
90Noes8Q0nwMFAgkMMusTw==	c9bc1f95-2d8a-4e42-abca-ca1d16e19e37	BRCA2	10.64	0.0	0.754	0.419	14	MILGPEDLSYQIYDVSGESNSAVSTED	MILGPEDLSYQIYYVSGESNSAVSTED
j6O8wfVgGBuUW9Fxv9IoCQ==	c9bc1f95-2d8a-4e42-abca-ca1d16e19e37	BRCA2	83.22	0.0	0.55	0.136	14	VAIYNPLLYSVSMSPRVYVPLITASYV	VAIYNPLLYSVSMCPRVYVPLITASYV
H2OUMJlmn68aGsDj5bxZXQ==	c9bc1f95-2d8a-4e42-abca-ca1d16e19e37	BRCA2	53.73	0.0	0.983	0.972	14	FLPEDIIIQTFEGWLLIKAQHGTRMDE	FLPEDIIIQTFEGKLLIKAQHGTRMDE
GSBGu2fbAz4ehNMkb4psGw==	c9bc1f95-2d8a-4e42-abca-ca1d16e19e37	BRCA2	67.1	0.0	0.498	0.677	14	LRMPLEMLKSEMTQNRQESFDIFEDEG	LRMPLEMLKSEMTSNRQESFDIFEDEG
DSUcR5KCDZl1CUouDdVCEQ==	40d0f1ca-1015-4c78-8994-1d7603b5d260	BRCA2	19.84	0.0	0.526	0.163	14	VSQIKLMHTKIDELRTLDSVSQISNID	VSQIKLMHTKIDEERTLDSVSQISNID
NZ9RC1PHXKBoaB63OSalSQ==	40d0f1ca-1015-4c78-8994-1d7603b5d260	BRCA2	53.01	0.0	0.21	0.559	14	KNPDLRRNVLCGAITPQQIAVMTSEEM	KNPDLRRNVLCGADTPQQIAVMTSEEM
wQg+Y9cT7dvNz3GNHy52zg==	40d0f1ca-1015-4c78-8994-1d7603b5d260	BRCA2	92.16	0.0	0.703	0.841	14	AALMISLIWKYYSVPVAVVPSKWITPL	AALMISLIWKYYSYPVAVVPSKWITPL
bfrkyrket778uUeH1FPM8w==	40d0f1ca-1015-4c78-8994-1d7603b5d260	BRCA2	80.05	0.0	0.177	0.492	14	YENMRFLITHNPTNATLNKFTEELKKY	YENMRFLITHNPTRATLNKFTEELKKY
zuFUqSEccWhDTlpRQeFHbQ==	40d0f1ca-1015-4c78-8994-1d7603b5d260	BRCA2	23.3	0.0	0.925	0.578	14	LLKAPTIVGKSSLNPILFRGVGMVADP	LLKAPTIVGKSSLHPILFRGVGMVADP
3QbiST9HLfkUrRxb7Hvo3g==	40d0f1ca-1015-4c78-8994-1d7603b5d260	BRCA2	61.57	0.0	0.539	0.532	14	WILWRFWHDSEEVLGHFPYPDPSQWTD	WILWRFWHDSEEVFGHFPYPDPSQWTD
/G1/KF4S9eUSe2O6XyWOkw==	40d0f1ca-1015-4c78-8994-1d7603b5d260	BRCA2	18.57	0.0	0.881	0.376	14	IKKQQIDSIMFDQAQTEIQSVMEENAY	IKKQQIDSIMFDQIQTEIQSVMEENAY
OI1qojwlbeu86Q49n7gQTA==	40d0f1ca-1015-4c78-8994-1d7603b5d260	BRCA2	34.07	0.0	0.204	0.993	14	LPIMIYAGLRSNQWGRSSCTINWPGES	LPIMIYAGLRSNQQGRSSCTINWPGES
UfV6Q3NP9UgnRWuudTKXWA==	40d0f1ca-1015-4c78-8994-1d7603b5d260	BRCA2	57.64	0.0	0.439	0.542	14	VGKTTNPIFNHTMVYDGFRPEDLMEAC	VGKTTNPIFNHTMNYDGFRPEDLMEAC
Nt7HaRrf6Zi+pQcDE9CG9A==	40d0f1ca-1015-4c78-8994-1d7603b5d260	BRCA2	75.95	0.0	0.687	0.903	14	GLWACTAECKILGHSDRCWSPSCSGPN	GLWACTAECKILGPSDRCWSPSCSGPN
N+xJLFOl5cQ4jNYVby9u8A==	31cd9c91-dc5d-4748-88d6-f08d08a5fda3	BRCA2	49.58	0.0	0.208	0.802	14	LSAVKYKGELQRGTAISDPPELKRAKE	LSAVKYKGELQRGCAISDPPELKRAKE
m0CxJWruQhk4GayuOw0LqA==	31cd9c91-dc5d-4748-88d6-f08d08a5fda3	BRCA2	21.44	0.0	0.58	0.635	14	CEENYSVTWYIAEFCSFLPSSLKSNLK	CEENYSVTWYIAEMCSFLPSSLKSNLK
VTs4Hl8IC0KZk7YXp9eQMQ==	31cd9c91-dc5d-4748-88d6-f08d08a5fda3	BRCA2	89.95	0.0	0.808	0.341	14	STQEIHEKVLNEAVGAMMYHTITLTRE	STQEIHEKVLNEAAGAMMYHTITLTRE
7LqehQvxwJuIljgyKpYK4w==	31cd9c91-dc5d-4748-88d6-f08d08a5fda3	BRCA2	28.03	0.0	0.491	0.319	14	QKSKDGNGGGGGGGGKKDSITYREVLE	QKSKDGNGGGGGGFGKKDSITYREVLE
aef4tD/eSHIJx50qThyY+A==	31cd9c91-dc5d-4748-88d6-f08d08a5fda3	BRCA2	89.07	0.0	0.669	0.837	14	AILGMDVLCQAKSGMGKTAVFVLATLQ	AILGMDVLCQAKSAMGKTAVFVLATLQ
EdpQQwIUBeudcqhwxOhxmw==	31cd9c91-dc5d-4748-88d6-f08d08a5fda3	BRCA2	72.36	0.0	0.268	0.38	14	MDFLGMKMVGELLRMSGAFFMRRTFGG	MDFLGMKMVGELLAMSGAFFMRRTFGG
Hf4VmeO2tzpRPxdxw9pgcA==	31cd9c91-dc5d-4748-88d6-f08d08a5fda3	BRCA2	24.17	0.0	0.989	0.712	14	GGGPEMDDYMETLKDEEDALWENVECN	GGGPEMDDYMETLEDEEDALWENVECN
WZ6a+tl01GJqr8Q+mkfQDQ==	31cd9c91-dc5d-4748-88d6-f08d08a5fda3	BRCA2	67.31	0.0	0.778	0.689	14	ENPDSGGNIYPRPKPRPQPQPGNSGNS	ENPDSGGNIYPRPGPRPQPQPGNSGNS
BGaYLX5CqcrHZF99C339tA==	31cd9c91-dc5d-4748-88d6-f08d08a5fda3	BRCA2	55.99	0.0	0.948	0.649	14	LLGCKYYSTAVDIWSLGCIFAEMHLVG	LLGCKYYSTAVDIPSLGCIFAEMHLVG
QibrBaCQ1rz/WPWTjEHuBQ==	31cd9c91-dc5d-4748-88d6-f08d08a5fda3	BRCA2	41.06	0.0	0.775	0.34	14	SDSSDTEEKDDDDDDEEDVGKREFVED	SDSSDTEEKDDDDNDEEDVGKREFVED
BTxZF1GLW1vN3xZnwrDgFw==	132687ee-aa51-4f88-9d1d-879c8ef72554	BRCA2	34.19	0.0	0.914	0.205	14	NGKQISGFGKKFYYKATVMFECDKGFY	NGKQISGFGKKFYHKATVMFECDKGFY
LdI7BoJV5W6FVwrfU9CLcQ==	132687ee-aa51-4f88-9d1d-879c8ef72554	BRCA2	50.22	0.0	0.574	0.956	14	MLGLREEKSEDQDLQGLKDKPLKFKKV	MLGLREEKSEDQDRQGLKDKPLKFKKV
gUIGiIF2akdOt1lH9J19BA==	132687ee-aa51-4f88-9d1d-879c8ef72554	BRCA2	80.83	0.0	0.351	0.456	14	NISATVLYITAFIACSAAVDLTSLRGT	NISATVLYITAFIDCSAAVDLTSLRGT
8ZYm9wTtLwqBLWRwOACTCg==	132687ee-aa51-4f88-9d1d-879c8ef72554	BRCA2	11.24	0.0	0.998	0.932	14	FKEAFNMIDQNRDGFIDKEDLHDMLAS	FKEAFNMIDQNRDPFIDKEDLHDMLAS
zMex6VbYO09U2cresB/kmA==	132687ee-aa51-4f88-9d1d-879c8ef72554	BRCA2	56.35	0.0	0.597	0.58	14	SSSQISGGHGLSITSKQWRRPGTPSLH	SSSQISGGHGLSINSKQWRRPGTPSLH
Ri6vIW5L7yRn9QixC+lxtQ==	132687ee-aa51-4f88-9d1d-879c8ef72554	BRCA2	73.14	0.0	0.585	0.686	14	HIPRKMPWQSSNHSFPTSIKCLTPHLK	HIPRKMPWQSSNHMFPTSIKCLTPHLK
7ii4zt0JxLlNTrKAGucuNw==	132687ee-aa51-4f88-9d1d-879c8ef72554	BRCA2	96.34	0.0	0.31	0.133	14	KAAKHKAAEVALKHLKGGSMLEPALED	KAAKHKAAEVALKGLKGGSMLEPALED
ffZWKV3iK/0neERuz6xJZw==	132687ee-aa51-4f88-9d1d-879c8ef72554	BRCA2	86.79	0.0	0.695	0.627	14	DILAVADWGQKVSFYQLSGKQIGKDRA	DILAVADWGQKVSDYQLSGKQIGKDRA
6oJ8f5VgGWKLkfmm7tkkPw==	132687ee-aa51-4f88-9d1d-879c8ef72554	BRCA2	42.96	0.0	0.916	0.879	14	FPYVEFTGRDSITCLTCQGTGYIPTGD	FPYVEFTGRDSITILTCQGTGYIPTGD
Vr3aQ7iKCe8obCIKM8SEzw==	132687ee-aa51-4f88-9d1d-879c8ef72554	BRCA2	55.04	0.0	0.493	0.796	14	LPGPFSYTVVLYGPAGLGKTTLAQKLM	LPGPFSYTVVLYGCAGLGKTTLAQKLM
4EssALgWD1bdTZsjJljsEw==	898a9491-f195-4afc-af61-0cdd885ed1e7	BRCA2	38.82	0.0	0.731	0.696	14	KSNLTLVNQSKGYEIKNSVEFTGNGDS	KSNLTLVNQSKGYNIKNSVEFTGNGDS
IMusx6E4QT88yYTgcWIm7w==	898a9491-f195-4afc-af61-0cdd885ed1e7	BRCA2	26.5	0.0	0.737	0.135	14	RQKSKRGRPPLKSTLSSNMPYGLSKTA	RQKSKRGRPPLKSWLSSNMPYGLSKTA
1CGOU+UbLloowzYct6NNjw==	898a9491-f195-4afc-af61-0cdd885ed1e7	BRCA2	46.08	0.0	0.896	0.404	14	RHVFGESDELIGQKVAHALAEGLGVIA	RHVFGESDELIGQNVAHALAEGLGVIA
l+xshyr3CLFeODHVM8lAaQ==	898a9491-f195-4afc-af61-0cdd885ed1e7	BRCA2	79.56	0.0	0.942	0.734	14	AKELWEKNGAVIMAVRRPGCFLCREEA	AKELWEKNGAVIMMVRRPGCFLCREEA
5m0aq7hnHJ2+RdbCeEoq/Q==	898a9491-f195-4afc-af61-0cdd885ed1e7	BRCA2	36.33	0.0	0.454	0.352	14	CPTNFCIFVETGFHHVGQACLELLTSG	CPTNFCIFVETGFEHVGQACLELLTSG
6CG26IVH6wM6vTlM4nU17g==	898a9491-f195-4afc-af61-0cdd885ed1e7	BRCA2	88.57	0.0	0.348	0.39	14	LKRETLLEIQKFLNGEDWKPGALDDAL	LKRETLLEIQKFLGGEDWKPGALDDAL
YWAf9NV7EqhG1Tn6DHJrlg==	898a9491-f195-4afc-af61-0cdd885ed1e7	BRCA2	54.42	0.0	0.624	0.549	14	GRHHRMDEFSRGNVPSSELQIYTWMDA	GRHHRMDEFSRGNDPSSELQIYTWMDA
Ss8lLKkA5zItbAiGa1EEMQ==	898a9491-f195-4afc-af61-0cdd885ed1e7	BRCA2	74.16	0.0	0.614	0.669	14	RHSADICAVPAESHIYREGCAQGLQKW	RHSADICAVPAESNIYREGCAQGLQKW
JKtOApBKo+zjlENDt0D7/Q==	898a9491-f195-4afc-af61-0cdd885ed1e7	BRCA2	97.09	0.0	0.827	0.413	14	LMCEGRRLKKRKTTTKKNTLNPVYNEA	LMCEGRRLKKRKTVTKKNTLNPVYNEA
Vmeksx8yQ+hshBkJZzxKgA==	898a9491-f195-4afc-af61-0cdd885ed1e7	BRCA2	71.66	0.0	0.877	0.702	14	CDDLIIRPLESQGIERLHPMQFDHKKE	CDDLIIRPLESQGHERLHPMQFDHKKE
tEnTb78JtBt51RCQtBxCIg==	870dd6a4-5aa5-41b6-888b-bdea8971ad09	BRCA2	53.88	0.0	0.676	0.116	14	LLPALLGPPRALSSLAAKMGEYRKMWN	LLPALLGPPRALSNLAAKMGEYRKMWN
89LEp1CiImaJixraUubdCw==	870dd6a4-5aa5-41b6-888b-bdea8971ad09	BRCA2	55.83	0.0	0.857	0.743	14	TSLSPFYLRPPSFLRAPSWFDTGLSEM	TSLSPFYLRPPSFTRAPSWFDTGLSEM
/dMD+Su5E0uVsyNX1CgGhA==	870dd6a4-5aa5-41b6-888b-bdea8971ad09	BRCA2	15.68	0.0	0.188	0.618	14	ESPLGHFESYGGMPFFQAQKMFVDVPE	ESPLGHFESYGGMEFFQAQKMFVDVPE
db1ktrvtP6T3z7INXlhMIQ==	870dd6a4-5aa5-41b6-888b-bdea8971ad09	BRCA2	11.85	0.0	0.515	0.391	14	FRSHPPSVRMPSSSLSESSPRPSFWER	FRSHPPSVRMPSSGLSESSPRPSFWER
wHG7ZBaZvll7Kr2/v3cmTw==	870dd6a4-5aa5-41b6-888b-bdea8971ad09	BRCA2	54.92	0.0	0.722	0.753	14	LAHFLHFHFYEINGITAALAEELFEKG	LAHFLHFHFYEINPITAALAEELFEKG
4QZUtDXhbBVtIoXhZK1Qjg==	870dd6a4-5aa5-41b6-888b-bdea8971ad09	BRCA2	86.94	0.0	0.221	0.276	14	APAEDPVFTILAPEDPPVPFRMMEDAE	APAEDPVFTILAPADPPVPFRMMEDAE
MrebforAlMJsHgHkvfMpGA==	870dd6a4-5aa5-41b6-888b-bdea8971ad09	BRCA2	52.07	0.0	0.849	0.453	14	LDCIRPRLLRVVPLNPKTPNVHQLQSH	LDCIRPRLLRVVPDNPKTPNVHQLQSH
wg6M43agPfOsVmeBbw88ng==	870dd6a4-5aa5-41b6-888b-bdea8971ad09	BRCA2	60.52	0.0	0.571	0.708	14	KGRKRKLESLDALEPEEKAEDCWELQI	KGRKRKLESLDALSPEEKAEDCWELQI
6vfpKJzwCBQjm4krkldhvQ==	870dd6a4-5aa5-41b6-888b-bdea8971ad09	BRCA2	79.18	0.0	0.847	0.159	14	SFDNYYSLLIDGPLDREQISEYQVLIT	SFDNYYSLLIDGPYDREQISEYQVLIT
nDmq9oijWr/FwiBcu6ipwg==	870dd6a4-5aa5-41b6-888b-bdea8971ad09	BRCA2	18.73	0.0	0.328	0.798	14	ADICPKCWTLMTMAIRIIDRALKEDFG	ADICPKCWTLMTMHIRIIDRALKEDFG
vPbi7/mTbGiY4OjSwvS3uQ==	331bdf8b-b837-47bc-8f7f-3d2626c8c385	BRCA2	57.26	0.0	0.934	0.503	14	LQKTLSMPSGPSGKRWSKDSDCAENMY	LQKTLSMPSGPSGSRWSKDSDCAENMY
sNfNAVuv0eSPW+jTfe+1Xg==	331bdf8b-b837-47bc-8f7f-3d2626c8c385	BRCA2	22.13	0.0	0.334	0.765	14	DSRSEAEAAKNALNGIRFDPEIPQTLR	DSRSEAEAAKNALTGIRFDPEIPQTLR
u1CGjHQqDgLRV4BfhQj6xA==	331bdf8b-b837-47bc-8f7f-3d2626c8c385	BRCA2	96.81	0.0	0.922	0.7	14	GKAEGRDEEQTDEELAVDLEALVSKAE	GKAEGRDEEQTDENLAVDLEALVSKAE
I1eiMC7PlWfcoZZAfFfqjA==	331bdf8b-b837-47bc-8f7f-3d2626c8c385	BRCA2	73.01	0.0	0.404	0.84	14	ESIRLPGCPRGVNPVVSYAVALSCQCA	ESIRLPGCPRGVNCVVSYAVALSCQCA
V0pMqZeEEoG41Bf3YQIH8w==	331bdf8b-b837-47bc-8f7f-3d2626c8c385	BRCA2	73.65	0.0	0.633	0.498	14	FFEVAVNGSSFVSFRPERALWQADTQV	FFEVAVNGSSFVSYRPERALWQADTQV
HT3gwlYhs5Wrna8/7nLkog==	331bdf8b-b837-47bc-8f7f-3d2626c8c385	BRCA2	97.2	0.0	0.489	0.141	14	KKAAEDKCKQVEEELTHLQKKLKGTED	KKAAEDKCKQVEESLTHLQKKLKGTED
WEMUpyqgK8QKQ5kXbhIUKQ==	331bdf8b-b837-47bc-8f7f-3d2626c8c385	BRCA2	89.01	0.0	0.494	0.948	14	SPRVLGLPSRMEPPAPLSTSSTSQASA	SPRVLGLPSRMEPCAPLSTSSTSQASA
JctWiGUvrS9yzZboKnPQtg==	331bdf8b-b837-47bc-8f7f-3d2626c8c385	BRCA2	35.33	0.0	0.218	0.196	14	LIQQNHIGSVIKQTDVSEDSNDDMDED	LIQQNHIGSVIKQVDVSEDSNDDMDED
tRALj7UzRS/VMlbl3acrIA==	331bdf8b-b837-47bc-8f7f-3d2626c8c385	BRCA2	59.98	0.0	0.773	0.877	14	GSKGLRVVKISWGQGHFWELWRSGLWN	GSKGLRVVKISWGWGHFWELWRSGLWN
4ldF9oR5KrLhMAVG6k+bIg==	331bdf8b-b837-47bc-8f7f-3d2626c8c385	BRCA2	22.22	0.0	0.367	0.747	14	RLKAALHDQLNRLKVEELALQSMISSR	RLKAALHDQLNRLEVEELALQSMISSR
SPMdSvmyKlUcCS6AWT2gJw==	1cc74a25-4f27-426f-81d3-c125427375b9	BRCA2	61.28	0.0	0.323	0.473	14	GDPDGFFNSKVALFAAVGAGCVIFLLI	GDPDGFFNSKVALHAAVGAGCVIFLLI
VItvcoWyY+tpX4q/YGNECg==	1cc74a25-4f27-426f-81d3-c125427375b9	BRCA2	35.03	0.0	0.998	0.327	14	ISLEKEEQIFVVIKDKPLSSIKADIVH	ISLEKEEQIFVVIPDKPLSSIKADIVH
8cFZDrnIcCuaS9HkS8NXdQ==	1cc74a25-4f27-426f-81d3-c125427375b9	BRCA2	50.82	0.0	0.104	0.849	14	LKCEFCGKMGYANEFLRSKRFCTMSCA	LKCEFCGKMGYANMFLRSKRFCTMSCA
BVlxY46LZOE3hGRVwiR6ew==	1cc74a25-4f27-426f-81d3-c125427375b9	BRCA2	20.33	0.0	0.385	0.8	14	ESISVSSEQLAQFRSLLSNVEGDNAVP	ESISVSSEQLAQFVSLLSNVEGDNAVP
tq45fBw5FhklOBNFMx/gkQ==	1cc74a25-4f27-426f-81d3-c125427375b9	BRCA2	35.59	0.0	0.662	0.612	14	RMQAFEASPMWLQDMKPRKNVSAAIPS	RMQAFEASPMWLQGMKPRKNVSAAIPS
eaM01WXheIrcpmdwOVQ2aA==	1cc74a25-4f27-426f-81d3-c125427375b9	BRCA2	16.99	0.0	0.735	0.629	14	AKGPSVGEVVPNVGPPEGAVTCETPTP	AKGPSVGEVVPNVLPPEGAVTCETPTP
gDNcqAbGnULld239ngs4dw==	1cc74a25-4f27-426f-81d3-c125427375b9	BRCA2	55.88	0.0	0.678	0.172	14	TVSRIYVEDKHKILYCEVPKAGCSNWK	TVSRIYVEDKHKIEYCEVPKAGCSNWK
EXHuUr/WkTtPni6hMGkimg==	1cc74a25-4f27-426f-81d3-c125427375b9	BRCA2	11.05	0.0	0.514	0.296	14	RKWARIREFVPPFGIKGQDNLIKAILS	RKWARIREFVPPFHIKGQDNLIKAILS
KZZcyXBdHsM7Gavx3yTTXA==	1cc74a25-4f27-426f-81d3-c125427375b9	BRCA2	14.49	0.0	0.621	0.256	14	NGTARAPGIPEAGSRRGQPAAAVAAAA	NGTARAPGIPEAGHRRGQPAAAVAAAA
j2uTVw4upAblEYxyM3Ch2g==	1cc74a25-4f27-426f-81d3-c125427375b9	BRCA2	31.14	0.0	0.435	0.388	14	SGPQPGGEEERGFLCASIYLQLSGAQP	SGPQPGGEEERGFQCASIYLQLSGAQP
2+CEHRITHgfmk88sf3xb4A==	b129ff41-77cc-40ed-ac74-94b3de0628c0	BRCA2	67.15	0.0	0.554	0.529	14	AAAARDPAQDEMDQTPPARPEYLVSGI	AAAARDPAQDEMDCTPPARPEYLVSGI
ZtGlsUTGocbfejSkF46Vpw==	b129ff41-77cc-40ed-ac74-94b3de0628c0	BRCA2	84.53	0.0	0.747	0.895	14	DWNKEVRRAAAQALGQMSLGKEVHDII	DWNKEVRRAAAQAKGQMSLGKEVHDII
Ws8Pn3e0k90yKkmqTdKSJg==	b129ff41-77cc-40ed-ac74-94b3de0628c0	BRCA2	49.74	0.0	0.144	0.939	14	CNITADRKVYPQADAVIVHHREVMYNP	CNITADRKVYPQAEAVIVHHREVMYNP
8aE5MILoWPcF+MJz1cfu0A==	b129ff41-77cc-40ed-ac74-94b3de0628c0	BRCA2	27.05	0.0	0.822	0.406	14	KGRGGWVPAALRSVSQDGVPGCTVMGG	KGRGGWVPAALRSRSQDGVPGCTVMGG
FzZxTHo4URaViC236PcAiA==	b129ff41-77cc-40ed-ac74-94b3de0628c0	BRCA2	26.18	0.0	0.296	0.878	14	FGVIIYKVFRHTAGLKPEVSCFENIRS	FGVIIYKVFRHTAPLKPEVSCFENIRS
5yyGXWLMEjj4i1pMJmwuTQ==	b129ff41-77cc-40ed-ac74-94b3de0628c0	BRCA2	94.62	0.0	0.497	0.378	14	EKQLDENANVQLSDEKIINIVLDLFGA	EKQLDENANVQLSAEKIINIVLDLFGA
7/yHcV5SZNa/lfi19UIULA==	b129ff41-77cc-40ed-ac74-94b3de0628c0	BRCA2	21.7	0.0	0.924	0.98	14	EINHFYCADPPLIKMACAGTFVKEYTM	EINHFYCADPPLIGMACAGTFVKEYTM
BCTBz4WplbD+FNVkWUTW6w==	b129ff41-77cc-40ed-ac74-94b3de0628c0	BRCA2	57.17	0.0	0.844	0.32	14	FLGQARTKSEMQNGGRCSTCSQDENSI	FLGQARTKSEMQNHGRCSTCSQDENSI
510vOWtsMDukbAC+WlkPRQ==	b129ff41-77cc-40ed-ac74-94b3de0628c0	BRCA2	38.93	0.0	0.835	0.999	14	GVRPPGWEAQINIISTRLALAHTAPAA	GVRPPGWEAQINICSTRLALAHTAPAA
N2p9ayXkCWErKhH+8bao3g==	b129ff41-77cc-40ed-ac74-94b3de0628c0	BRCA2	28.81	0.0	0.52	0.529	14	IVNDELYLNGASVLPHKSIGESVPEPR	IVNDELYLNGASVQPHKSIGESVPEPR
